Untreated Adult Acute Lymphoblastic Leukemia Withdrawn Phase 2 Trials for Prednisone (DB00635)
Indication | Status | Phase |
---|---|---|
DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia) | Withdrawn | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01670084 | Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia | Treatment |